Cargando…

Putative autoantibodies in the cerebrospinal fluid of Alzheimer’s disease patients

Background: Recent efforts have described an immunogenic component to the pathobiology of Alzheimer’s disease (AD) and Parkinson’s disease (PD). However, current methods of studying fluid autoantibodies, such as enzyme-linked immunosorbent assays and immunohistochemistry, are hypothesis-driven and n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Bryant, Tsolaki, Magda, Batruch, Ihor, Anastasiou, Anna, Frontistis, Antonis, Prassas, Ioannis, Diamandis, Eleftherios P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008601/ https://www.ncbi.nlm.nih.gov/pubmed/32089828 http://dx.doi.org/10.12688/f1000research.21140.1

Ejemplares similares

Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer’s disease progression
por: Begcevic, Ilijana, et al.
Publicado: (2018)

A proteome-wide immuno-mass spectrometric identification of serum autoantibodies
por: Music, Milena, et al.
Publicado: (2019)

Correction to: A proteome-wide immuno-mass spectrometric identification of serum autoantibodies
por: Music, Milena, et al.
Publicado: (2019)

Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry
por: Cretu, Daniela, et al.
Publicado: (2014)

Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis
por: Sohaei, Dorsa, et al.
Publicado: (2023)

Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas
por: Begcevic, Ilijana, et al.
Publicado: (2016)

Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers
por: Cretu, Daniela, et al.
Publicado: (2015)

Predicting response and toxicity to PD-1 inhibition using serum autoantibodies identified from immuno-mass spectrometry
por: Music, Milena, et al.
Publicado: (2020)

Towards personalized tumor markers
por: Kulasingam, Vathany, et al.
Publicado: (2017)

Case Report: Alzheimer's Dementia Associated With Cerebrospinal Fluid Neurochondrin Autoantibodies
por: Hansen, Niels, et al.
Publicado: (2022)

Unraveling endometriosis-associated ovarian carcinomas using integrative proteomics
por: Leung, Felix, et al.
Publicado: (2018)

Bioinformatic identification of proteins with tissue-specific expression for biomarker discovery
por: Prassas, Ioannis, et al.
Publicado: (2012)

Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer’s disease and associated with CSF-TAU and FDG-PET
por: Goldhardt, Oliver, et al.
Publicado: (2019)

Borrelia valaisiana in Cerebrospinal Fluid
por: Diza, Eudoxia, et al.
Publicado: (2004)

Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics
por: Tijms, Betty M, et al.
Publicado: (2020)

Increased Levels of Antigen-Bound β-Amyloid Autoantibodies in Serum and Cerebrospinal Fluid of Alzheimer’s Disease Patients
por: Maftei, Madalina, et al.
Publicado: (2013)

The origin and nature of the complex autoantibody profile in cerebrospinal fluid
por: Kheirkhah, Rahil, et al.
Publicado: (2019)

Thyroid Autoantibodies in the Cerebrospinal Fluid of Subjects with and without Thyroid Disease: Implications for Hashimoto's Encephalopathy
por: Ilias, Ioannis, et al.
Publicado: (2015)

Characterization of the seminal plasma proteome in men with prostatitis by mass spectrometry
por: Kagedan, Daniel, et al.
Publicado: (2012)

Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line
por: Vasiliou, Stella K., et al.
Publicado: (2022)

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
por: Konijnenberg, Elles, et al.
Publicado: (2020)

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
por: Khoonsari, Payam Emami, et al.
Publicado: (2016)

Putative Concussion Biomarkers Identified in Adolescent Male Athletes Using Targeted Plasma Proteomics
por: Miller, Michael R., et al.
Publicado: (2021)

Electroencephalogram and Alzheimer's Disease: Clinical and Research Approaches
por: Tsolaki, Anthoula, et al.
Publicado: (2014)

Deciphering the peptidome of urine from ovarian cancer patients and healthy controls
por: Smith, Christopher R, et al.
Publicado: (2014)

Proteomic Signatures of the Desmoplastic Invasion Front Reveal Collagen Type XII as a Marker of Myofibroblastic Differentiation During Colorectal Cancer Metastasis
por: Karagiannis, George S., et al.
Publicado: (2012)

Comparison of two multiplexed technologies for profiling >1,000 serum proteins that may associate with tumor burden
por: Ren, Annie, et al.
Publicado: (2021)

Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid
por: Czech, Christian, et al.
Publicado: (2012)

Alzheimer disease pathology and the cerebrospinal fluid proteome
por: Dayon, Loïc, et al.
Publicado: (2018)

Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017)

Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
por: Visser, Pieter Jelle, et al.
Publicado: (2022)

Quantification of angiotensin II-regulated proteins in urine of patients with polycystic and other chronic kidney diseases by selected reaction monitoring
por: Konvalinka, Ana, et al.
Publicado: (2016)

Investigating a novel multiplex proteomics technology for detection of changes in serum protein concentrations that may correlate to tumor burden
por: Ren, Annie He, et al.
Publicado: (2020)

Cerebrospinal Fluid Anti-Neuronal Autoantibodies in COVID-19-Associated Limbic Encephalitis with Acute Cerebellar Ataxia and Myoclonus Syndrome: Case Report and Literature Review
por: Yiannopoulou, Konstantina, et al.
Publicado: (2023)

Distinct serum and cerebrospinal fluid cytokine and chemokine profiles in autoantibody-associated demyelinating diseases
por: Hofer, Livia S, et al.
Publicado: (2019)

Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
por: Visser, Pieter Jelle, et al.
Publicado: (2022)

Six autoantibodies associated with autoimmune encephalitis are not detectable in the cerebrospinal fluid of suicide attempters
por: Fernström, Johan, et al.
Publicado: (2017)

High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms
por: Franke, Christiana, et al.
Publicado: (2021)

Autoimmune obsessive-compulsive disorder with novel anti-CNS autoantibodies in cerebrospinal fluid
por: Endres, Dominique, et al.
Publicado: (2022)

High frequency of cerebrospinal fluid autoantibodies in patients with seizures or epilepsies of unknown etiology
por: Schulz, Paulina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b066svb1325bmb4la1bgpnclb0